Home › Funds › Sands Capital Alternatives, LLC › CADL
Sands Capital Alternatives, LLC position in CADL
CANDEL THERAPEUTICS INC · Health Care
Sands Capital Alternatives, LLC reported holding 405,837 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.63% of its reported portfolio and ranking #22 among its reported holdings. Sands Capital Alternatives, LLC has disclosed CADL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sands Capital Alternatives, LLC's CADL position evolved
Sands Capital Alternatives, LLC first disclosed a stake in CADL in Q3 2023 at 811,737 shares (US$747K). The position peaked in Q3 2026 at 405,837 shares, worth US$4.2M. Across 13 filings, Sands Capital Alternatives, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 405,837 shares valued at US$4.2M. Notable position changes include a 50% trim in Q2 2024 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 811.74K | $746.80K | New |
| Q4 2023 | 811.74K | $1.19M | Hold |
| Q1 2024 | 811.74K | $1.28M | Hold |
| Q2 2024 | 405.84K | $2.52M | Reduce |
| Q3 2024 | 405.84K | $2.81M | Hold |
| Q4 2024 | 405.84K | $3.52M | Hold |
| Q1 2025 | 405.84K | $2.29M | Hold |
| Q2 2025 | 405.84K | $2.05M | Hold |
| Q3 2025 | 405.84K | $2.07M | Hold |
| Q4 2025 | 405.84K | $2.29M | Hold |
| Q1 2026 | 405.84K | $1.99M | Hold |
| Q2 2026 | 405.84K | $4.18M | Hold |
| Q3 2026 | 405.84K | $4.24M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CADL and 13F data
CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 78 other funds we track also report a position in CADL — the largest reported positions include RTW INVESTMENTS, LP (US$66.1M), ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CADL
- RTW INVESTMENTS, LP 6.42M sh · $66.15M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 3.50M sh · $36.03M · Q2 2026
- Portolan Capital Management, LLC 3.49M sh · $35.95M · Q2 2026
- Saturn V Capital Management LP 3.30M sh · $34.03M · Q2 2026
- Tanager Wealth Management LLP 198.18K sh · $2.07M · Q3 2026
- ACT Capital Partners, L.P. 150.50K sh · $1.57M · Q3 2026
- Kynam Capital Management, LP 96.74K sh · $996.43K · Q2 2026
More on Sands Capital Alternatives, LLC
FAQ
How long has Sands Capital Alternatives, LLC held CADL?
Sands Capital Alternatives, LLC has disclosed CADL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sands Capital Alternatives, LLC's current position in CADL?
As of Q3 2026, Sands Capital Alternatives, LLC holds 405.84K shares of CADL (CANDEL THERAPEUTICS INC), valued at $4.24M, representing 0.63% of its reported portfolio and ranking #22.
Has Sands Capital Alternatives, LLC been buying or selling CADL?
In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in CADL. The position peaked in Q3 2026 at 405.84K shares.
Which other funds hold CADL?
Other major institutional holders of CADL include RTW INVESTMENTS, LP, ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.